Dec 10 · McLean, VA: Network with investors and see emerging startups pitch live. Register →

Companies Currently Raising

Industry key:

November 12 Presenting Companies

Organized by industry, scroll down for the full list of industries



Bringing the Internet to Over 1 billion Unconnected


Our Freeze-on-Demand machine & pod technology is revolutionizing the way ice cream & frozen beverages are produced, transported, & enjoyed around the world.

Old-fashioned technology makes CPR unsafe. Compact Medical is on a mission to change that.

 A premier EV charging managed service provider that specializes in the management, governance, and optimization of EV charging ecosystems.
Click on a Company’s name for contact information.

Organized by Industry

 
Want your company to be part of our exclusive listing?
Email us at srallison@opus8.com for more details!

 

For a full list of alumni, click here.


Ginkgo-AI builds the control plane for AI in regulated environments.



A social platform that’s transforming the way we interact online.

The Funding Platform for Every Family. Simple, One-Stop Funding. Every Age. Every Stage.

A next-generation AH-64 Apache flight simulator developed by DigiFlight.

Revolutionizing agriculture with advanced gene editing.



Revolutionizing plant breeding for a sustainable future.

Disrupting old elevator tech with vertical hyperloop for elegance and freedom in any multi-story home or office.


An inventory cash-recovery practice for independent, owner-operated retailers.


A clinical stage biopharmaceutical company developing a novel platform technology to treat multiple cancer types.


Breaking the chains of opioid addiction.




Develops & commercializes medical devices with integrated motion that improve patient outcomes.



Engineering the Future of Medicine. Creating Supernatural Peptides™ to access previously undruggable targets for a transformative positive impact on human health​.


Tools for real, lasting recovery.
Less Pain. More Life.



AI and Regenerative Biology to design peptides that improve and extend lives​.



Cost-Effective Plant-Based Adhesives and Protective Coatings.

C2C



C2C is dedicated to innovative medical research and revolutionizing the development of medical devices.



Innovative Solutions for Common Eye Conditions, Dry Eye, and Pink Eye.

Dasion provides crucial machine learning and artificial intelligence that enables fast and explainable clinical support at the click of a button.


Easily is a prescription toothpaste that treats the root cause of allergies while you brush your teeth.



Enamel Pure enables the safe, effective application of laser cleaning in any dentist’s office.


Frenelle PBC is developing FRN01, a once-monthly subcutaneous buprenorphine injection for Opioid Use Disorder (OUD), and is backed by Mayo Clinic Ventures.

Developing novel therapeutics for unmet medical needs in metastatic castration-resistant prostate cancer, NASH liver fibrosis, & type 2 diabetes.

At the forefront of a revolutionary holistic approach to the management of depression.



Improving patient outcomes in solid tumor cancer treatment.


A retinal biotech company improving eyesight in patients whose vision has been impaired by dry age-related macular degeneration.


Engineering novel nanoimmunotherapies by combining the principles of nanotechnology and immunotherapy to treat cancer.




The strength of steel. The soul of wood.


The next generation of brain monitoring. Revolutionizing patient care through advanced neuromonitoring and AI.

Fermentation-based platform providing a cost-competitive, environmentally friendly alternative to the traditional petroleum supply chain for sulfur ingredients.


The Only Provider-Driven Software for sleep clinics that delivers insomnia care at scale.



Early Cancer Screening. Better Outcomes.


Developing novel immunotherapies for chronic viral infections and virus-driven cancers.


A disruptor of the $1.5T inflammation market with proven assets, bold IP, and a high-impact leadership team.

Revolutionizing endovascular solutions for dialysis access and peripheral artery disease (PAD).


Innovative RNA-based test to enhance early infection detection and reduce treatment costs for a healthier future.



Developing a device to address the unmet need for Full-Brain protection




Developing investigational antivirals for improved disease management and patient outcomes.